Expert second opinions for mitral regurgitation. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Mitral Regurgitation (MR) is the most common valvular heart disease, affecting over 4 million Americans. If you are facing a decision about mitral regurgitation, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Mitral regurgitation (MR) is the most common valvular heart disease, affecting over 4 million Americans. The mitral valve fails to close properly, allowing blood to leak backward into the left atrium. Primary (degenerative) MR involves structural valve abnormalities, while secondary (functional) MR results from LV dysfunction.
The distinction between repair and replacement has profound long-term implications. Repair preserves native valve tissue and avoids anticoagulation, but requires specialized surgical expertise. Surgeon-specific repair rates vary dramatically — from less than 50% to over 99% — and this data is rarely shared with patients.
Surgery for mitral regurgitation depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. The distinction between repair and replacement has profound long-term implications. Repair preserves native valve tissue and avoids anticoagulation, but requires specialized surgical expertise. Surgeon-specific repair rates vary dramatically — from less than 50% to over 99% — and this data is rarely shared with patients.
Operative mortality for mitral regurgitation-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for mitral regurgitation depends on anatomy, comorbidities, age, and personal goals. Repair vs replacement (surgeon repair rates matter enormously). A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.